康健國際醫療(03886.HK)中期扭虧為盈至551.8萬港元
格隆匯8月27日丨康健國際醫療(03886.HK)公佈,截至2021年6月30日止6個月,公司實現收入7.22億港元,同比增加65.15%;公司擁有人應占期內淨利551.8萬港元,去年同期則虧損9396.8萬港元,扭虧為盈;每股淨利0.07港仙。
收入增加主要歸因於截至2021年6月30日止6個月對(a)醫療服務;(b)中國內地醫院管理及相關服務;及(c)2019冠狀病毒病檢測服務的需求增加。
集團自疫情爆發以來,全體上下一心做好防疫措施,以保障員工及病人的安全為首要任務,回顧期內旗下所擁有或管理的醫療服務機構在香港和內地均實現"零感染",抗疫佳績令人振奮。
同時,集團不遺餘力支持香港政府抗擊2019冠狀病毒病疫情,集團聯合香港政府認可的醫療檢測機構在總部大樓提供場地合作開設的一所大型2019冠狀病毒病核酸檢測化驗中心,於回顧期內已處理逾二百三十萬宗檢測,不但有效提升地的整體檢測能力,更為集團帶來理想回報。長遠而言,疫情大幅提升了市民對於醫療健康的重視,集團將積極把握醫療行業的發展機遇,推進各業務板塊全速向前,致力於為市民帶來更全面的優質醫療服務,併為股東創造更大的價值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.